Hsien Lai, Samuel
Zervoudakis, Guston
Chou, Jesse
Gurney, Mark E.
Quesnelle, Kelly M. http://orcid.org/0000-0002-2408-1904
Article History
Received: 8 January 2020
Revised: 2 March 2020
Accepted: 3 March 2020
First Online: 20 March 2020
Compliance with ethical standards
:
: MG is an employee of Tetra Discovery Partners, Inc. that has a financial interest in the discovery and development of PDE4B and PDE4D allosteric inhibitors for the treatment of Fragile X Syndrome, Alzheimer’s disease, and other CNS disorders.